Structural Formula (Diclofenac Dr Tablets Carlsbad 1)
Diclofenac Sodium Delayed Release Tablet, Delayed Release
Product Images NDC 70882-128
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium Delayed Release (NDC 70882-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cambridge Therapeutics Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cti 103 Imprint (Diclofenac Dr Tablets Carlsbad 2)
Diclofenac Sodium Delayed-release Tablets, Usp 75 mg (Diclofenac Dr Tablets Carlsbad 3)
This is a description of Diclofenac Sodium Delayed-Release Tablets, USP, that contains 30 tablets each containing 75mg of the active ingredient, Diclofenac Sodium USP. The dosage instructions are available in the insert supplied with the product, and the package should be stored in a light-resistant container as defined in the USP. The package features a child-resistant lock release that encourages re-insertion for child safety. The blister card has tamper-evident protection, and the product should not be used if the package is broken, the blister card backing is torn, or individual blisters are open. The product is to be dispensed with a medication guide and available only via a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
